PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES - INCORPORATE RATE LETTER MOD | Pandemic PACT Tracker

Key facts

Disease
Ebola, Marburg virus disease
Start & end year
2022
2027
Known Financial Commitments (USD)
$134,839,788.58
Funder
Biomedical Advanced Research and Development Authority (BARDA)
Research Location
United States of America
Lead Research Institution
MAPP BIOPHARMACEUTICAL, INC.
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES - INCORPORATE RATE LETTER MOD